Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to- Moderate Cardiovascular Risk: An International Expert Consultation Alberto Morales Salinas, MD, MPH, a , * Antonio Coca, MD, PhD, b Michael H.Olsen, MD, PhD, c Ramiro A. Sanchez, MD, d Weimar K. Sebba-Barroso, MD, e Richard Kones, MD, f Vicente Bertomeu-Martinez, MD, PhD, g Javier Sobrino, MD, PhD, h Luis Alcocer, MD, i Daniel J Pineiro, MD, j Fernando Lanas, MD, PhD, k Carlos A Machado, MD, l Fernando Aguirre-Palacios, MD, m Jose Ortellado, MD, n Gonzalo Perez, MD, o Rodrigo Sabio, MD, p Orlando Landrove, MD, q Delfin Rodriguez-Leyva, MD, PhD, r Alfredo Duenas-Herrera, MD, s Ayelen Rodriguez Portelles r Jose Z. Parra-Carrillo, MD, t Daniel L. Piskorz, MD, u Alfonso Bryce-Moncloa, MD, v Gabriel Waisman, MD, w YuichiroYano, MD, x Hector Ventura, MD, y Marcelo Orias, MD, z Dorairaj Prabhakaran, MD, aa J. Sundstr o¨ m, MD, bb Jiguang Wang, MD, cc Louise M. Burrell, MD, dd Alta E. Schutte, MD, PhD, ee Patricio Lopez-Jaramillo, MD, ff Eduardo Barbosa, MD, gg Josep Redon, MD, hh Michael A.Weber, MD, ii Authors declare no conflicts of interest regarding the content of this article. *Corresponding author. Dr. Alberto Morales Salinas, Chairperson, Colon 473 e/ Estrada Palma y Misionero, Santa Clara, Villa Clara, Cuba, CP 50100. E-mail: cardioams@yahoo.es Curr Probl Cardiol 2017;42:198–225. 0146-2806/$ – see front matter http://dx.doi.org/10.1016/j.cpcardiol.2017.03.001 198 Curr Probl Cardiol, July 2017